Les appels du Cluster 1 - Santé

Sommaire

Global Calls for Cluster 1 - Health Projects

HORIZON-HLTH-2026-02

Partnerships in Health (2026/1)

Topic(s) Title Budget disponible (€) Action(s) Ouverture Clôture Clôture (2nde étape)
HORIZON-HLTH-2026-02-DISEASE-12 European Partnership on Rare Diseases (ERDERA) (Phase 2) 48 700 000 HORIZON Programme Cofund Actions 10/02/2026
15/09/2026
118 jours
Topic(s)
118 jours
HORIZON-HLTH-2026-02-DISEASE-12
European Partnership on Rare Diseases (ERDERA) (Phase 2)
Clôture : 15/09/2026
Clôture (2nde étape) :

HORIZON-HLTH-2026-03

Partnerships in Health (2026/2)

Topic(s) Title Budget disponible (€) Action(s) Ouverture Clôture Clôture (2nde étape)
HORIZON-HLTH-2026-03-DISEASE-13 European Partnership for Pandemic Preparedness (Phase 2) 30 000 000 HORIZON Programme Cofund Actions 10/02/2027
13/04/2027
328 jours
Topic(s)
328 jours
HORIZON-HLTH-2026-03-DISEASE-13
European Partnership for Pandemic Preparedness (Phase 2)
Clôture : 13/04/2027
Clôture (2nde étape) :

HORIZON-HLTH-2027-01

Cluster 1 - Health (Single stage - 2027/1)

Topic(s) Title Budget disponible (€) Action(s) Ouverture Clôture Clôture (2nde étape)
HORIZON-HLTH-2027-01-DISEASE-08 Development of innovative antimicrobials against pathogens resistant to antimicrobials 44 200 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
328 jours
HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03 Tools and technologies to support health adaptation to climate change 20 000 000 HORIZON Pre-commercial Procurement 10/02/2027
13/04/2027
328 jours
HORIZON-HLTH-2027-01-ENVHLTH-02 Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change 45 000 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
328 jours
HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications 38 000 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
328 jours
HORIZON-HLTH-2027-01-STAYHLTH-01 Addressing disabilities through the life course to support independent living and inclusion 39 300 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
328 jours
HORIZON-HLTH-2027-01-DISEASE-05 Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential 44 200 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
328 jours
HORIZON-HLTH-2027-01-DISEASE-07 Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses 37 300 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
328 jours
HORIZON-HLTH-2027-01-DISEASE-06 Development of monoclonal antibodies to prevent and treat infections from Flaviviruses 37 300 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
328 jours
HORIZON-HLTH-2027-01-IND-01 Development of cell-free protein synthesis platforms for discovery and/or production of biologicals 24 500 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
328 jours
HORIZON-HLTH-2027-01-DISEASE-10 Prevention and management of chronic non-communicable diseases in children and young people (GACD) 11 800 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
328 jours
Topic(s)
328 jours
HORIZON-HLTH-2027-01-DISEASE-08
Development of innovative antimicrobials against pathogens resistant to antimicrobials
Clôture : 13/04/2027
Clôture (2nde étape) :
328 jours
HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03
Tools and technologies to support health adaptation to climate change
Clôture : 13/04/2027
Clôture (2nde étape) :
328 jours
HORIZON-HLTH-2027-01-ENVHLTH-02
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
Clôture : 13/04/2027
Clôture (2nde étape) :
328 jours
HORIZON-HLTH-2027-01-CARE-02
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Clôture : 13/04/2027
Clôture (2nde étape) :
328 jours
HORIZON-HLTH-2027-01-STAYHLTH-01
Addressing disabilities through the life course to support independent living and inclusion
Clôture : 13/04/2027
Clôture (2nde étape) :
328 jours
HORIZON-HLTH-2027-01-DISEASE-05
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Clôture : 13/04/2027
Clôture (2nde étape) :
328 jours
HORIZON-HLTH-2027-01-DISEASE-07
Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Clôture : 13/04/2027
Clôture (2nde étape) :
328 jours
HORIZON-HLTH-2027-01-DISEASE-06
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Clôture : 13/04/2027
Clôture (2nde étape) :
328 jours
HORIZON-HLTH-2027-01-IND-01
Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
Clôture : 13/04/2027
Clôture (2nde étape) :
328 jours
HORIZON-HLTH-2027-01-DISEASE-10
Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Clôture : 13/04/2027
Clôture (2nde étape) :

HORIZON-HLTH-2027-02-two-stage

Cluster 1 - Health (Two stage - 2027)

Topic(s) Title Budget disponible (€) Action(s) Ouverture Clôture Clôture (2nde étape)
HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases 44 200 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
22/09/2027
328 jours
HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases 39 300 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
22/09/2027
328 jours
HORIZON-HLTH-2027-02-IND-02-two-stage Portable and versatile Point-of-care diagnostics 39 300 000 HORIZON Innovation Actions 10/02/2027
13/04/2027
22/09/2027
328 jours
HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases 63 800 000 HORIZON Research and Innovation Actions 10/02/2027
13/04/2027
22/09/2027
328 jours
Topic(s)
328 jours
HORIZON-HLTH-2027-02-TOOL-01-two-stage
Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Clôture : 13/04/2027
Clôture (2nde étape) : 22/09/2027
328 jours
HORIZON-HLTH-2027-02-DISEASE-14-two-stage
Clinical trials for advancing innovative interventions for neurodegenerative diseases
Clôture : 13/04/2027
Clôture (2nde étape) : 22/09/2027
328 jours
HORIZON-HLTH-2027-02-IND-02-two-stage
Portable and versatile Point-of-care diagnostics
Clôture : 13/04/2027
Clôture (2nde étape) : 22/09/2027
328 jours
HORIZON-HLTH-2027-02-DISEASE-01-two-stage
Innovative healthcare interventions for non-communicable diseases
Clôture : 13/04/2027
Clôture (2nde étape) : 22/09/2027

HORIZON-HLTH-2027-03

Cluster 1 - Health (Single stage - 2027/2)

Topic(s) Title Budget disponible (€) Action(s) Ouverture Clôture Clôture (2nde étape)
HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare 2 900 000 HORIZON Coordination and Support Actions 03/06/2027
22/09/2027
490 jours
HORIZON-HLTH-2027-03-TOOL-02 Advancing bio-printing of living cells for regenerative medicine 39 300 000 HORIZON Research and Innovation Actions 03/06/2027
22/09/2027
490 jours
HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis 39 300 000 HORIZON Research and Innovation Actions 03/06/2027
22/09/2027
490 jours
Topic(s)
490 jours
HORIZON-HLTH-2027-03-TOOL-08
Towards Artificial General Intelligence (AGI) for healthcare
Clôture : 22/09/2027
Clôture (2nde étape) :
490 jours
HORIZON-HLTH-2027-03-TOOL-02
Advancing bio-printing of living cells for regenerative medicine
Clôture : 22/09/2027
Clôture (2nde étape) :
490 jours
HORIZON-HLTH-2027-03-TOOL-04
Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
Clôture : 22/09/2027
Clôture (2nde étape) :